Author:
Zuo Jiaxuan,Li Hengcun,Zhang Shutian,Li Peng
Funder
Beijing Hospitals Authority "Dengfeng" talent training plan
National Key Research and Development Program of China
Publisher
Springer Science and Business Media LLC
Reference91 articles.
1. Mäkelä A, Kuusi T, Schröder T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest 1997;57:401–407.
2. Gross V, Leser HG, Heinisch A, Schölmerich J. Inflammatory mediators and cytokines–new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993;40:522–530.
3. Li L, Liu M, Zhang T, Jia Y, Zhang Y, Yuan H, et al. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography. Scand J Gastroenterol 2019;54:793–799.
4. Geng C, Li X, Li Y, Song S, Wang C. Nonsteroidal anti-inflammatory drugs alleviate severity of post-endoscopic retrograde cholangiopancreatography pancreatitis by inhibiting inflammation and reducing apoptosis. J Gastroenterol Hepatol 2020;35:896–904.
5. Murray B, Carter R, Imrie C, Evans S, O’Suilleabhain C. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003;124:1786–1791.